Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PTLA | Portola Pharmaceuticals, Inc. | 0.00% | 17.83 | 6.5% | $162.99m | |
| HZNP | Horizon Therapeutics Plc | 3.40% | 49.56 | 6.5% | $137.49m | |
| MYOK | MyoKardia, Inc. | 0.72% | 107.50 | 1.8% | $136.24m | |
| BHC | Bausch Health Cos., Inc. | -2.26% | 17.77 | 0.0% | $116.19m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -2.26% | 17.77 | 14.1% | $104.56m | |
| CTLT | Catalent, Inc. | 0.37% | 78.59 | 2.3% | $99.65m | |
| AXSM | Axsome Therapeutics, Inc. | -2.48% | 80.90 | 1.9% | $79.79m | |
| UTHR | United Therapeutics Corp. | 0.32% | 117.57 | 14.3% | $76.94m | |
| AMRN | Amarin Corp. Plc | -0.55% | 7.24 | 1.6% | $69.65m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -12.19% | 80.51 | 16.8% | $59.84m | |
| GWPH | GW Pharmaceuticals Plc | 1.33% | 126.92 | 6.2% | $55.95m | |
| JAZZ | Jazz Pharmaceuticals Plc | -1.14% | 109.59 | 2.4% | $53.60m | |
| PRGO | Perrigo Co. Plc | 0.00% | 54.33 | 6.8% | $48.45m | |
| ICLR | ICON plc | 1.07% | 166.51 | 4.3% | $45.86m | |
| SAGE | SAGE Therapeutics, Inc. | 2.53% | 38.94 | 8.6% | $40.94m |
Company Profile
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.